|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Pancreatic neuroendocrine tumor and solid-pseudopapillary neoplasm: Key immunohistochemical profiles for differential diagnosis显示文摘AIM To reveal better diagnostic markers for differentiating neuroendocrine tumor(NET) from solid-pseudopapillary neoplasm(SPN), focusing primarily on immunohistochemical analysis.METHODS We reviewed 30 pancreatic surgical specimens of NET(24 cases) and SPN(6 cases). We carried out comprehensive immunohistochemical profiling using 9 markers: Synaptophysin, chromogranin A, pancytokeratin, E-cadherin, progesterone receptor,vimentin, α-1-antitrypsin, CD10, and β-catenin.RESULTS E-cadherin staining in NETs, and nuclear labeling of β-catenin in SPNs were the most sensitive and specific markers. Dot-like staining of chromogranin A might indicate the possibility of SPNs rather than NETs. The other six markers were not useful because their expression overlapped widely between NETs and SPNs. Moreover, two cases that had been initially diagnosed as NETs on the basis of their morphological features, demonstrated SPN-like immunohistochemical profiles. Careful diagnosis is crucial as we actually found two confusing cases showing disagreement between the tumor morphology and immunohistochemical profiles.CONCLUSION E-cadherin, chromogranin A, and β-catenin were the most useful markers which should be employed for differentiating between NET and SPN. | Yusuke Ohara Tatsuya Oda Shinji Hashimoto Yoshimasa Akashi Ryoichi Miyamoto Tsuyoshi Enomoto Kaishi Satomi Yukio Morishita Nobuhiro Ohkohchi | 2016 | World Journal of Gastroenterology2016，22，38： | 19 |
| 2 | A rare case of hyaline-type Castleman disease in the liver显示文摘Castleman disease often develops in the neck, mediastinum and pulmonary hilum. Its onset in the peritoneal cavity is very rare. The patient, a woman in her 70s, was referred to our department for a detailed examination of an abdominal mass. On abdominal ultrasonography, computed tomography scan, magnetic resonance imaging and positron emission tomography, a mass approximately 15 mm in diameter was noted in the hepatic S6. We attempted radical treatment and conducted a laparoscope-assisted right lobectomy. On the basis of histopathological findings, the patient was diagnosed as having hyaline type Castleman disease in the liver, a very rare condition. | Hisaaki Miyoshi Shima Mimura Takako Nomura Joji Tani Asahiro Morishita Hideki Kobara Hirohito Mori Hirohito Yoneyama Akihiro Deguchi Takashi Himoto Naoki Yamamoto Keiichi Okano Yasuyuki Suzuki Tsutomu Masaki | 2013 | World Journal of Hepatology2013，5，7： | 14 |
| 3 | 腰痛患者MRI上各节段腰椎间盘退变形式与年龄的相关性分析显示文摘目的:探讨腰痛患者MRI上各节段腰椎间盘退变形式与年龄的相关性。方法:回顾性分析2004~2006年共529例就诊于加州大学洛杉矶分校Santa Monica骨科医院脊柱外科中心的腰痛伴或不伴有腿痛患者(男191例,女338例)的腰椎MRI资料,根据患者年龄分为5组,≤29岁、30~39岁、40~49岁、50~59岁及≥60岁组。按Pfirrmann′s分级系统对每例患者腰椎各节段的椎间盘(L1/2~L5/S1)退变程度进行分级,所得数据采用SPSS13.0进行统计学分析,总结其退变模式。结果:71例(13.4%)患者L1/2~L5/S1椎间盘退变程度表现为1-1-1-1-1,为正常椎间盘,是所有组合中最常见的。低年龄组发生严重退变(4级)的几率最低,L1/2、L2/3、L3/4椎间盘退变程度较L4/5、L5/S1低;1-1-1-1-1的发生率随着年龄的增加而明显降低,而1-1-1-1-2和1-1-1-1-3与之相反,发生率随着年龄的增加而明显升高。40岁以前,1-1-1-1-1的发生率最高;在40~49岁年龄组中,1-1-1-1-3的发生几率最高,为7.6%,而超过50岁,3-3-3-3-3发生的几率最高。单节段退变发生率与年龄呈负相关(P<0.01),随着年龄的增大而降低;而所有节段退变的发生率与年龄呈正相关(P<0.01),随着年龄的增大而增加。结论:在腰痛患者中,腰椎单一节段退变所占比例随年龄增大而减小,而所有节段退变所占比例随年龄增大而增大。 | 蒋欣 Yuiehiro Morishita Hymanson Henry Jeffrey C.Wang | 2009 | 中国脊柱脊髓杂志2009，19，11： | 9 |
| 4 | Reduction effect of bacterial counts by preoperative saline lavage of the stomach in performing laparoscopic and endoscopic cooperative surgery显示文摘AIM:To investigate the effects of gastric lavage with2000 mL of saline in laparoscopic and endoscopic cooperative surgery.METHODS:Twenty two patients who were diagnosed with a gastric gastrointestinal stromal tumor were enrolled.In former term,irrigations of the stomach were conducted whenever it was necessary,not systematically(Non systemic lavage group).In latter term,the stomach was thoroughly cleaned with 2000 mL of saline using an endoscope with a water jet,and Duodenal balloon occlusion was conducted to prevent refluxedbile and pancreatic juice(Systemic lavage+balloon occlusion group).The gastric wall was sprayed with 20mL of distilled water,and 20 mL of gastric juice was collected in a sterile tube and submitted for culture.20mL of ascites was also collected from the laparoscopic ports and submitted for culture.We compared WBC,CRP,BT between two groups,and verify the reduction effect of bacterial counts in Systemic lavage+balloon occlusion group.RESULTS:WBC count before,1 d after,and 3 d after laparoscopic and endoscopic cooperative surgery(LECS)were 5060(95%CI:4250-9640),12140(6050-14110),and 6910(5320-12520)in Non systemic lavage group,4400(3660-7620),8910(6480-10980),and 5950(4840-7860)in Systemic lavage+balloon occlusion group.Significant differences between two groups at the day after LECS(P=0.029)and the 3 d after LECS(P=0.042).CRP levels in Non systemic lavage group and in Systemic lavage+balloon occlusion group were significantly different at the day after LECS(P=0.005)and the 3 d after LECS(P=0.028).BTs(℃)in Non systemic lavage group and in Systemic lavage+balloon occlusion group were also significantly different at the day after LECS(P=0.004)and the 3 d after LECS(P=0.006).In a logarithmic comparison,bacterial load before gastric lavage,after lavage,and ascites culture were 6.08(95%CI:4.04-6.97),0.48(0-0.85),and 0.21(0-0.56).The bacterial counts before and after gastric lavage were significantly suppressed(P=0.007),but no significant difference between gastric juice culture after lavage and ascites(P=0.154).CONCLUSION:Pre-LECS lavage with 2000 mL of saline exhibited a bacteria-reducing effect equivalent to disinfectants and obtained favorable results in terms of clinical symptoms and data. | Hirohito Mori Hideki Kobara Takaaki Tsushimi Shintaro Fujihara Noriko Nishiyama Tae Matsunaga Maki Ayaki Tatsuo Yachida Joji Tani Hisaaki Miyoshi Asahiro Morishita Tsutomu Masaki | 2014 | World Journal of Gastroenterology2014，20，42： | 9 |
| 5 | 用于空气中水蒸气吸-脱附的微孔泡沫炭制备研究(英文)显示文摘以蜜胺泡沫体为模板,采用氟化聚酰亚胺制备了微孔泡沫炭。测定了其对环境中水气的吸附/脱附行为,发现:泡沫炭在空气中400℃活化1h,可以提高其对水气的吸附能力。与活化前相比,对水气的吸附量几乎高达3倍,尽管其微孔容积仅增大了1.5倍。对环境水气中的可逆吸附率与微孔容积成线性关系,微孔容积为0.75mL/g的泡沫炭,其水气吸附率约为质量分数40%。 | Naoto Ohta Yoko Nishi Takahiro Morishita Yumiko Ieko Akifumi Ito Michio Inagaki | 2008 | 新型炭材料2008，23，3： | 7 |
| 6 | Diabetes mellitus and metformin in hepatocellular carcinoma显示文摘Hepatocellular carcinoma(HCC) is the leading cause of cancer-related death worldwide. Diabetes mellitus, a risk factor for cancer, is also globally endemic. The clinical link between these two diseases has been the subject of investigation for a century, and diabetes mellitus has been established as a risk factor for HCC. Accordingly, metformin, a first-line oral anti-diabetic, was first proposed as a candidate anti-cancer agent in 2005 in a cohort study in Scotland. Several subsequent large cohort studies and randomized controlled trials have not demonstrated significant efficacy for metformin in suppressing HCC incidence and mortality in diabetic patients; however, two recent randomized controlled trials have reported positive data for the tumor-preventive potential of metformin in non-diabetic subjects. The search for biological links between cancer and diabetes has revealed intracellular pathways that are shared by cancer and diabetes. The signal transduction mechanisms by which metformin suppresses carcinogenesis in cell lines or xenograft tissues and improves chemoresistance in cancer stem cells have also been elucidated. This review addresses the clinical and biological links between HCC and diabetes mellitus and the anti-cancer activity of metformin in clinical studies and basic experiments. | Koji Fujita Hisakazu Iwama Hisaaki Miyoshi Joji Tani Kyoko Oura Tomoko Tadokoro Teppei Sakamoto Takako Nomura Asahiro Morishita Hirohito Yoneyama Tsutomu Masaki | 2016 | World Journal of Gastroenterology2016，22，27： | 7 |
| 7 | Targeting receptor tyrosine kinases in gastric cancer显示文摘Molecularly targeted therapeutic agents are constantly being developed and have been shown to be effective in various clinical trials.One group of representative targeted oncogenic kinases,the receptor tyrosine kinases(RTKs),has been associated with gastric cancer development.Trastuzumab,an inhibitor of ERBB2,has been approved for the treatment of gastric cancer,although other receptor tyrosine kinases,such as epidermal growth factor receptor,vascular endothelial growth factor,platelet-derived growth factor receptor,c-Met,IGF-1R and fibroblast growth factor receptor 2,are also activated in gastric cancer.The promising results of the trastuzumab clinical trial for gastric cancer resulted in the approval of trastuzumab-based therapy as a first-line treatment for human epidermal growth factor receptor 2-positive patients.On the other hand,the trial examining bevacizumab in combination with conventional chemotherapy did not meet its primary goal of increasing the overall survival time of gastric cancer patients;however,a significantly higher response rate and a longer progression-free survival were observed in the bevacizumab arm of the trial.Other clinical trials,especially phaseⅢtrials that have tested drugs targeting RTKs,such as cetuximab,panitumumab,gefitinib,erlotinib,figitumumab,sorafenib,sunitinib and lapatinib,have shown that these drugs have modest effects against gastric cancer.This review summarizes the recent results from the clinical trials of molecularly targeted drugs and suggests that further improvements in the treatment of advanced gastric cancer can be achieved through the combination of conventional drugs with the new molecularly targeted therapies. | Asahiro Morishita Jian Gong Tsutomu Masaki | 2014 | World Journal of Gastroenterology2014，20，16： | 5 |
| 8 | Matrix metalloproteinase-2 as a superior biomarker for peritoneal deterioration in peritoneal dialysis显示文摘AIM: To investigate the efficacy of effluent biomarkers for peritoneal deterioration with functional decline in peritoneal dialysis(PD). METHODS: From January 2005 to March 2013, the subjects included 218 PD patients with end-stage renal disease at 18 centers. Matrix metalloproteinase-2(MMP-2), interleukin-6(IL-6), hyaluronan, and cancer antigen 125(CA125) in peritoneal effluent were quantified with enzyme-linked immunosorbent assay. Peritoneal solute transport rate was assessed by peritoneal equilibration test(PET) to estimate peritoneal deterioration. RESULTS: The ratio of the effluent level of creatinine(Cr) obtained 4 h after injection(D) to that of plasma was correlated with the effluent levels of MMP-2(ρ = 0.74, P < 0.001), IL-6(ρ = 0.46, P < 0.001), and hyaluronan(ρ = 0.27, P < 0.001), but not CA125(ρ = 0.13, P = 0.051). The area under receiver operating characteristic curve for the effluent levels of MMP-2, IL-6, and hyaluronan against high PET category were 0.90, 0.78, 0.62, and 0.51, respectively. No patient developed new-onset encapsulating peritoneal sclerosis for at least 1.5 years after peritoneal effluent sampling.CONCLUSION: The effluent MMP-2 level most closely reflected peritoneal solute transport rate. MMP-2 can be a reliable indicator of peritoneal deterioration with functional decline. | Ichiro Hirahara Eiji Kusano Yoshiyuki Morishita Makoto Inoue Tetsu Akimoto Osamu Saito Shigeaki Muto Daisuke Nagata | 2016 | World Journal of Nephrology2016，5，2： | 4 |
| 9 | “Zinkote 21”和“Silverzinc 21”表面无铬处理电镀和热镀锌钢板显示文摘开发了“Zinkote 21”和“Silverzinc 21”两种无铬表面处理钢板,与传统的铬酸盐处理产品具有相当或更优的耐蚀性能、电导率、润滑性能、耐擦伤性能、耐指纹性能、耐露点性能及漆膜附着性能。即使形变部位,也具有良好的耐蚀性能,在用碱性脱脂剂或溶剂进行脱脂后依然能保持良好的耐蚀性能。这两种环保产品可用来替代传统的铬酸盐处理钢板。 | Atsushi Morishita Akira Takahashi Makoto Nakazawa 齐慧滨(译) 钱余海(校) | 2006 | 世界钢铁2006，6，4： | 4 |
| 10 | Effect of the anti-diabetic drug metformin in hepatocellular carcinomain vitro and in vivo显示文摘 | Hisaaki Miyoshi Kiyohito Kato Hisakazu Iwama Emiko Maeda Teppei Sakamoto Koji Fujita Yuka Toyota Joji Tani Takako Nomura Shima Mimura Mitsuyoshi Kobayashi Asahiro Morishita Hideki Kobara Hirohito Mori Hirohito Yoneyama Akihiro Deguchi Takashi Himoto Kazut | 2014 | International Journal of Oncology2014，，1： | 3 |
| 11 | The relationship between tyrosine kinase inhibitor therapy and overall survival in patients with non-small cell lung cancer carrying EGFR mutations显示文摘For patients with epidermal growth factor receptor (EGFR) mutation-positive lung cancer, the relationship between the dose or duration of treatment with tyrosine kinase inhibitor (TKI) and overall survival remains unclear. Here, we analyzed clinical data of 39 patients who were diagnosed with EGFR mutation-positive non-small cell lung cancer and treated with TKI, but subsequently died. Several parameters were measured in this study: overall survival; first, second, and overall TKI therapy durations; first TKI intensity (actual dose/normal dose); and TKI rate (overall TKI therapy duration/overall survival). The response rate to TKI therapy was 50% , and the median survival was 553 days. After TKI therapy failed, 38.5% patients were re-challenged with TKI. We observed a moderate relationship [r = 0.534, 95% confidential interval (CI) = 0.263 to 0.727, P < 0.001] between overall TKI therapy duration and overall survival. However, we found no relationship between overall survival and first TKI intensity (r = 0.073, 95% CI = -0.380 to 0.247, P = 0.657) or TKI rate (r = 0.0345, 95% CI = -0.284 to 0.346, P = 0.835). Nonsmall cell lung cancer patients with mutation-positive tumors remained on TKI therapy for, on average, 33% of the overall survival time. These findings suggest that patients with EGFR mutation-positive tumors should not stick to using TKIs. | Hidekazu Suzuki Tomonori Hirashima Norio Okamoto Tadahiro Yamadori Motohiro Tamiya Naoko Morishita Takayuki Shiroyama Tomoyuki Otsuka Kanako Kitai Ichiro Kawase | 2013 | Chinese Journal of Cancer2013，32，3： | 3 |
| 12 | Periostin as a Novel Factor Responsible for Ventricular Dilation显示文摘 | Naruto Katsuragi Ryuichi Morishita Noriko Nakamura Tayehito Ochiai Yoshiaki Taniyama Yasuhiro Hasegawa Kayoko Kawashima Yasufumi Kaneda Toshio Ogihara Keijiro Sugimura | 2004 | Circulation2004，，13： | 2 |
| 13 | Usefulness of liver infiltrating CD86-positive mononuclear cells for diagnosis of autoimmune hepatitis显示文摘瞄准:尽管位于自体免疫的肝炎(AIH ) 下面的病原的机制仍然保持不清楚,免疫系统被认为为疾病的前进批评。细胞的有免疫力的回答可以在 AIH 被连接到肝细胞损坏。最近,许多注意集中于在有效 T 调停房间的有免疫力的回答的产生在单音的原子房间上表示的 costimulatory 分子的批评功能。与 AIH 从病人在单音的原子房间上表示的 costimulatory 分子的分析可以在 AIH 给我们卓见进肝细胞损坏的病原的机制。方法:单音的原子房间(PBMC ) 与 AIH (34 个盒子) 和健康控制(25 个盒子) 从病人被拿的外部血。渗透的单音的原子房间(LIMC ) 与 AIH (18 个盒子) 从病人被拿的肝,有长期的丙肝(CH-C )(13 个盒子) 的病人和有脂肝(2 个盒子) 的病人。用流动血细胞计数,房间为 costimulatory 分子的表示被分析,例如 CD80, CD86,和 CD152 (CTLA-4 ) 。结果与象到 corticosteroids 的 corticosteroids 管理和反应的 gammaglobulin,组织学的等级,存在或缺席的水平那样的临床的数据相比。结果:CD80+ , CD86+ 和 CD152+ PBMC 的层次显著地作为与健康控制相比与 AIH 在病人被减少。由对比,那些房间比在有 AIH 的病人的 PBMC 在 LIMC 是显著地更高的。特别,不管疾病活动的度, CD86+ LIMC 的水平与 AIH 在病人显示出显著增加,尽管 CD86+ 房间是很少在 PBMC 在场。CD86+ 房间的层次显著地是在场的在里面在有 AIH 的病人的高频率比在有 CH-C 的病人。而且,有有 CD86+ LIMC 的高水平的 AIH 的病人显示出好回答到 corticosteroids,而有 CD86+ LIMC 的底层的 AIH 的 2 个盒子没反应很好。结论:这些结果建议那 LIMC 过去表示的 costimulatory 分子象 CD80 和 CD86 那样看起来在 AIH 的致病起一个作用。特别,在 LIMC 上表示的 CD86 分子可能为 AIH 的诊断并且为 AIH 上的 corticosteroids 的治疗学的效果的预言是有用的。 | Kazutaka Kurokohchi Tsutomu Masaki Takashi Himoto Akihiro Deguchi Seiji Nakai Asahiro Morishita Hirohito Yoneyama Yasuhiko Kimura Seishiro Watanabe Shigeki Kuriyama | 2006 | World Journal of Gastroenterology2006，12，16： | 2 |
| 14 | A Multicenter Survey of the Management After Gastric Endoscopic Submucosal Dissection Related to Postoperative Bleeding显示文摘 | Osamu Goto Mitsuhiro Fujishiro Ichiro Oda Naomi Kakushima Yorimasa Yamamoto Yosuke Tsuji Ken Ohata Takashi Fujiwara Junko Fujiwara Naoki Ishii Chizu Yokoi Shinichi Miyamoto Toshiyuki Itoh Shinji Morishita Takuji Gotoda Kazuhiko Koike | 2012 | Digestive Diseases and Sciences2012，，2： | 2 |
| 15 | Altered Cognitive Function of Prefrontal Cortex During Error Feedback in Patients With Irritable Bowel Syndrome, Based on fMRI and Dynamic Causal Modeling显示文摘 | Emiko Aizawa Yasuhiro Sato Takanori Kochiyama Naohiro Saito Masahiro Izumiyama Joe Morishita Motoyori Kanazawa Keisetsu Shima Hajime Mushiake Michio Hongo Shin Fukudo | 2012 | Gastroenterology2012，，5： | 2 |
| 16 | Seismic response reduction of a three-story building by an MR grease damper显示文摘 | Tomoki SAKURAI Shin MORISHITA | 2017 | Frontiers of Mechanical Engineering2017，12，2： | 2 |
| 17 | M phase specific kinetochore proteins in fission yeast: microtubuleassociating Dis1 and Mtc1 display rapid seperation and segregation during anaphase显示文摘 | Nakaseko Y Goshima G Morishita J | 2001 | Curr Biol2001，11，8： | 2 |
| 18 | 骶骨整块切除骨盆环重建治疗骶骨骨巨细胞瘤的疗效观察显示文摘目的:探讨骶骨整块切除及骨盆环重建治疗骶骨骨巨细胞瘤的方法与疗效。方法:2003年1月~2006年1月加州大学洛杉矶分校Santa Monica骨科医院脊柱外科中心收治骶骨骨巨细胞瘤患者8例,男5例,女3例,手术时年龄30~72岁,平均46岁。术前腰骶部CT扫描和MRI检查证实肿瘤均累及S1,采用一期前后路联合手术,术中结扎髂内动脉、髂腰动脉和骶正中动脉,显微镜下将肿瘤组织连同整块骶骨完整切除,用骨盆环假体重建腰骶髂关节稳定性。术后采用Toronto Extremity Salvage Score(TESS)评分系统对患者的功能恢复情况进行评价。结果:术中失血量800~2500ml,平均1200ml,手术时间490~720min,平均600min。病理学诊断:骨巨细胞瘤ⅡB期5例,Ⅲ期3例。术后卧床6~14d,平均10d,无1例患者术后并发切口感染。出院时患者均能不借助拐杖行走,恢复了日常生活自理能力。所有患者随访28~64个月,平均43个月,TESS评分由术前平均56.38分提高到73.25分。1例患者(Ⅲ期)术后18个月发生肺转移,接受肺叶切除,同时行放疗,随访至40个月时仍然存活;其余7例患者至末次随访时均存活,没有发现局部复发。结论:骶骨肿瘤累及S1时可行骶骨全切以提高肿瘤切除的彻底性,改善预后;采用骨盆环假体重建稳定性术后可早期活动。 | 蒋欣 韦竑宇 Yuichiro Morishita Hymanson Henry Jeffrey C.Wang | 2009 | 中国脊柱脊髓杂志2009，19，2： | 2 |
| 19 | Current Innovations in Endoscopic Therapy for the Management of Colorectal Cancer: From Endoscopic Submucosal Dissection to Endoscopic Full-Thickness Resection显示文摘 | Shintaro Fujihara Hirohito Mori Hideki Kobara Noriko Nishiyama Tae Matsunaga Maki Ayaki Tatsuo Yachida Asahiro Morishita Kunihiko Izuishi Tsutomu Masaki Hirotoshi Kobayashi | 2014 | BioMed Research International2014，，： | 2 |
| 20 | Kinematic evaluation of the adjacent segments after lumbar instrumented surgery: a comparison between rigid fusion and dynamic non-fusion stabilization显示文摘 | Yuichiro Morishita Hideki Ohta Masatoshi Naito Yoshiyuki Matsumoto George Huang Masato Tatsumi Yoshiharu Takemitsu Hirotaka Kida | 2011 | European Spine Journal2011，，9： | 2 |
您所在的机构暂未开通此部分的功能，请联系管理员